Aptahem AB logo

APTA TO 2 - Aptahem AB News Story

SEK0.001 0.0  0.0%

Last Trade - 16/05/18

Sector
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1827

BRIEF-Aptahem Reports Delay In Delivery Of Its Drug Product

Fri 8th February, 2019 7:43am
Feb 8 (Reuters) - Aptahem AB  APTA.TE :
    * APTAHEM REPORTS DELAY IN DELIVERY OF ITS DRUG PRODUCT
    * APTAHEM ANTICIPATES THAT COMMENCEMENT OF PLANNED CLINICAL
STUDY
FOR APTA-1 WILL BE DELAYED.
    * MANUFACTURE OF ITS DRUG PRODUCT HAS BEEN DELAYED AS A
RESULT OF
TECHNICAL CHALLENGES
    * A NEED TO HAVE MORE DRUG PRODUCT MANUFACTURED WAS
ANNOUNCED IN A
PRESS RELEASE ON AUGUST 28, 2018 DURING PRECLINICAL TOXICOLOGY
PROGRAM.
    * PLANNED CLINICAL STUDY WILL NOT START DURING Q3 THIS YEAR
AS
PREVIOUSLY COMMUNICATED.
    * DELAY IS DUE TO A SERIES OF TECHNICAL DIFFICULTIES THAT
HAVE
BEEN ENCOUNTERED DURING CONTRACT MANUFACTURER'S PRODUCTION.

Source text for Eikon:  ID:nWkr5vbK5M 
Further company coverage:  APTA.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.